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Background
Drug discovery from natural products is still one of the
biggest sources of novel lead compounds. In particular,
plant cyclotides, disulfide-rich peptides comprising three
conserved disulfide bonds in a knotted arrangement,
known as cyclic cystine knot motif, and a head-to-tail
cyclization, have been extensively investigated over the
last four decades for their use as scaffolds in drug devel-
opment. However, their distribution among flowering
plants still remains limited to few species of the families
of Rubiaceae (coffee), Violaceae (violet), Cucurbitaceae
(cucurbit), Fabaceae (bean) and recently Solanaceae
(potato family), but it is very likely that cyclotides are
more widely distributed since their predicted number in
Rubiaceae alone is ~50.000. Additionally, the pharmaco-
logical validation of plants used in traditional medicines
may trigger the discovery of novel uterotonic compounds
[1].
Methods and results
Based on the use of plants in traditional Nigerian medicine
during pregnancy and childbirth, we analyzed several
plants from different families to evaluate their uterotonic
properties at cellular level and to identify cyclotides as
active molecules. Using a MALDI-TOF/TOF-based
screening protocol we were able to identify many novel
cyclotide-containing species which was confirmed by man-
ual de novo sequencing and automated database identifica-
tion. The aqueous extracts and semipure peptide fractions
have been tested further in a collagen gel contractility
assay model and showed varying ability to induce contrac-
tions in human myometrial smooth muscle cells.
Conclusions
In conclusion, our results underpin earlier suggestions
that cyclotides are one of the largest peptide classes
within plants, covering a large chemical space based on
their high sequence diversity. The evaluation of contrac-
tile properties of plants used in traditional medicines
offers new starting points for the discovery and develop-
ment of peptide-based uterotonic drug leads.
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